Key result
Subxiphoid percutaneous pulsed field ablation demonstrates feasibility for epicardial premature ventricular contractions.
Why the study?
Outcomes of RFCA for epicardial ventricular arrhythmias may be limited by technical challenges and risk of injury to adjacent structures, especially near proximal coronary arteries.
Case Report
Answers are grounded in this paper and cite their sources.
Clinical report demonstrates pulsed field ablation feasibility for epicardial ventricular arrhythmias via subxiphoid access, indicating a safer alternative to thermal ablation.
Radiofrequency catheter ablation (RFCA) is a well-established treatment of idiopathic outflow tract ventricular arrhythmias (VAs), with high success rates ranging from 80% to 90%.1,2 However, outcomes may be less favorable when VAs originate from epicardial sites because of the technical challenges associated with dry epicardial puncture. Coronary veins have been identified as potential alternatives for mapping and ablating epicardial VAs.3 In cases of distinct VAs characterized by an abrupt loss of the R wave in lead V2 compared with leads V1 and V3—referred to as the pattern break in lead V2 (PBV2)—which suggests an origin near the anterior interventricular sulcus and adjacent to proximal coronary arteries, RFCA may be limited by catheter accessibility and the risk of injury to adjacent structures.
No takes yet. Share an insight, caveat, or question.
Que et al. (2026) conducted a case report in Epicardial Premature Ventricular Contractions. Pulsed Field Ablation via Subxiphoid Percutaneous Approach was evaluated. Pulsed field ablation via a subxiphoid percutaneous approach is presented for epicardial premature ventricular contractions, though no clinical outcomes are reported in the abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: